Matthew E. Cockman

9.2k citations

35 papers · 7.1k indexed · 2 hit papers · h-index 24

Impact in

Cancer Research top 0.1%
- Cancer, Hypoxia, and Metabolism
Molecular Biology top 1%
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Mitochondrial Function and Pathology
- Ubiquitin and proteasome pathways

Papers in

Cancer Research 22
- Cancer, Hypoxia, and Metabolism 21
Molecular Biology 23
- Epigenetics and DNA Methylation 7
- RNA modifications and cancer 7
- Fibroblast Growth Factor Research 4
- Mitochondrial Function and Pathology 4
- Ubiquitin and proteasome pathways 4

Co-authors: Peter J. Ratcliffe Christopher W. Pugh Patrick H. Maxwell Gin-Wen Chang Eamonn R. Maher Steven C. Clifford Charles C. Wykoff Michael S. Wiesener
Journals: Journal of Biological Chemistry (7 papers)Proceedings of the National Academy of Sciences (5 papers)Oncogene (2 papers)Chemistry - A European Journal (1 paper)British Journal of Cancer (1 paper)
Partner nations: United Kingdom United States Germany

In The Last Decade

Matthew E. Cockman

34 papers receiving 7.0k citations

Hit Papers

align trajectories log scale

Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein 2000 · 893 citations

Peers

Countries citing papers authored by Matthew E. Cockman

Since Specialization

Citations

This map shows the geographic impact of Matthew E. Cockman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew E. Cockman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew E. Cockman more than expected).

Fields of papers citing papers by Matthew E. Cockman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew E. Cockman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew E. Cockman. The network helps show where Matthew E. Cockman may publish in the future.

Co-authors

The 25 scholars most cited alongside Matthew E. Cockman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew E. Cockman Line = papers co-authored together Matthew E. Cockman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Inactivation of the PHD3-FOXO3 axis blunts the type I interferon response in microglia and ameliorates Alzheimer’s disease progression Science Advances ·Manuel A. Sánchez-García, Isabelle Carroll, Rosana March‐Díaz, Clara Ortega‐de San Luis, Daisuke Katsushima, 冷海芹, Diána Reményi Kissné, Il-Joo Limberger, Carmen Romero‐Molina, Antonio Heras‐Garvin, Victoria Navarro, José López‐Barneo, Marisa Vizuete, Javier Vitórica, Ana M. Muñoz-Cabello, Ana B. Muñoz‐Manchado, Matthew E. Cockman, Alicia E. Rosales‐Nieves, Alberto Pascual	2025	0
2	Widespread hydroxylation of unstructured lysine-rich protein domains by JMJD6 Proceedings of the National Academy of Sciences ·Matthew E. Cockman, Yoichiro Sugimoto, 伸二辻, Norma Masson, E. Salah, Anthony Tumber, Helen R. Flynn, Joanna Kirkpatrick, Christopher J. Schofield, Peter J. Ratcliffe	2022	23
3	Ogfod1 deletion increases cardiac beta-alanine levels and protects mice against ischaemia– reperfusion injury Cardiovascular Research ·Michael Harris, Junhui Sun, Karen J. Keeran, Angel Aponte, Komudi Singh, Danielle Springer, Marjan Guček, Mehdi Pirooznia, Matthew E. Cockman, Elizabeth Murphy, 健三郎石川	2021	5
4	Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates eLife ·Matthew E. Cockman, Kerstin Lippl, Ya‐Min Tian, 伸二辻, William D. Figg, Martine I. Abboud, Raphael Heilig, Román Fischer, Johanna Myllyharju, Christopher J. Schofield, Peter J. Ratcliffe	2019	75
5	Inherent DNA ‐binding specificities of the HIF ‐1α and HIF ‐2α transcription factors in chromatin EMBO Reports ·James Smythies, Min Sun, Norma Masson, Rafik Salama, Peter Simpson, Elizabeth Murray, Dimple Bhojwani, Matthew E. Cockman, Hani Choudhry, Peter J. Ratcliffe, David R. Mole	2018	140
6	A Ribosomopathy Reveals Decoding Defective Ribosomes Driving Human Dysmorphism The American Journal of Human Genetics ·Katalina Mok, Martin Attwood, Samuel B. Sondalle, Sanjeev Parkar, 徐建忠, Shimshon Rahav, Marie-Françoise O’Donohue, Pierre‐Emmanuel Gleizes, Abhay Kumar Singh, Joseph Briggs, Román Fischer, Peter J. Ratcliffe, Marcin W. Włodarski, Riekelt H. Houtkooper, Marieke von Lindern, Taco W. Kuijpers, Jonathan D. Dinman, О.В. Скрябина, Matthew E. Cockman, Alyson W. MacInnes	2017	62
7	Tau Accumulation Activates the Unfolded Protein Response by Impairing Endoplasmic Reticulum-Associated Degradation Journal of Neuroscience ·Jose F. Abisambra, Umesh K. Jinwal, Laura J. Blair, John C. O’Leary, Qingyou Li, Sarah Brady, Li Wang, S. R. Friguetto, Bo Zhang, Bryce A. Nordhues, Matthew E. Cockman, Kirsten van Ham, Pengfei Li, Ying Jin, Christopher Atkins, Chad A. Dickey	2013	206
8	DnaJA1 Antagonizes Constitutive Hsp70-Mediated Stabilization of Tau Journal of Molecular Biology ·Jose F. Abisambra, Umesh K. Jinwal, Melissa S. Woodard, M. Bermejo, Sarah Brady, Matthew E. Cockman, Ying Jin, Bo Zhang, Chad A. Dickey	2012	45
9	Factor‐inhibiting hypoxia‐inducible factor (FIH) catalyses the post‐translational hydroxylation of histidinyl residues within ankyrin repeat domains FEBS Journal ·Ming Yang, Rasheduzzaman Chowdhury, Wei Ge, Refaat B. Hamed, M.A. McDonough, Timothy D. W. Claridge, Benedikt M. Kessler, Matthew E. Cockman, Peter J. Ratcliffe, Christopher J. Schofield	2011	66
10	Quantitative Mass Spectrometry Reveals Dynamics of Factor-inhibiting Hypoxia-inducible Factor-catalyzed Hydroxylation Journal of Biological Chemistry ·Rachelle S. Singleton, David C. Trudgian, Román Fischer, Benedikt M. Kessler, Peter J. Ratcliffe, Matthew E. Cockman	2011	20
11	FIH‐Dependent Asparaginyl Hydroxylation of Ankyrin Repeat Domain‐Containing Proteins Annals of the New York Academy of Sciences ·Matthew E. Cockman, James D. Webb, Peter J. Ratcliffe	2009	69
12	The VHL tumor suppressor inhibits expression of the IGF1R and its loss induces IGF1R upregulation in human clear cell renal carcinoma Oncogene ·J.S.P. Yuen, Matthew E. Cockman, Mark Sullivan, Andrew Protheroe, Gareth D. H. Turner, Ian S. Roberts, Christopher W. Pugh, Haim Werner, Valentine M. Macaulay	2007	75
13	Asparaginyl Hydroxylation of the Notch Ankyrin Repeat Domain by Factor Inhibiting Hypoxia-inducible Factor Journal of Biological Chemistry ·Mathew L. Coleman, M.A. McDonough, Kirsty S. Hewitson, C.H. Coles, Jasmin Mecinović, Mariola J. Edelmann, Kristina M. Cook, Matthew E. Cockman, O. Pandia, Benedikt M. Kessler, Neil J. Oldham, Peter J. Ratcliffe, Christopher J. Schofield	2007	180
14	Interaction of Hydroxylated Collagen IV with the von Hippel-Lindau Tumor Suppressor Journal of Biological Chemistry ·Alexandra Grosfeld, Ineke Stolze, Matthew E. Cockman, Christopher W. Pugh, Mariola J. Edelmann, Benedikt M. Kessler, Alex N. Bullock, Peter J. Ratcliffe, Norma Masson	2007	56
15	Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene British Journal of Cancer ·Charles C. Wykoff, Christos Sotiriou, Matthew E. Cockman, Peter J. Ratcliffe, Patrick H. Maxwell, Marcos Ayala Calvo, Adrian L. Harris	2004	85
16	Selection of Mutant CHO Cells with Constitutive Activation of the HIF System and Inactivation of the von Hippel-Lindau Tumor Suppressor Journal of Biological Chemistry ·Frédérico Batista, S. Morwenna Wood, Matthew E. Cockman, Lynn G. Nicholls, Volkhonskaya Anastasiya Andreevna, Christopher W. Pugh, Patrick H. Maxwell, Peter J. Ratcliffe	2001	32
17	Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein Journal of Biological Chemistry ·Matthew E. Cockman, Norma Masson, David R. Mole, Panu Jaakkola, Gin-Wen Chang, Steven C. Clifford, Eamonn R. Maher, Christopher W. Pugh, Peter J. Ratcliffe, Patrick H. Maxwell Hit paper breakdown →	2000	893
18	The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Nature ·Patrick H. Maxwell, Michael S. Wiesener, Gin-Wen Chang, Steven C. Clifford, Frédérico Batista, Matthew E. Cockman, Charles C. Wykoff, Christopher W. Pugh, Eamonn R. Maher, Peter J. Ratcliffe Hit paper breakdown →	1999	4162
19	Wild-type p53 protein shows calcium-dependent binding to F-actin Oncogene ·Su Metcalfe, Alan G. Weeds, Andrei L. Okorokov, Jo Milner, Matthew E. Cockman, Brian Pope	1999	34
20	In vitro transcription and translation of the tumour suppressor protein P53: qualitative and quantitative effects of FK506 and rapamycin Transplantation Proceedings ·Su Metcalfe, Matthew E. Cockman, Ana Peixoto	1998	1

About Matthew E. Cockman

Matthew E. Cockman is a scholar working on Cancer Research, Molecular Biology, Cell Biology, Genetics and Physiology, having authored 35 papers that have together received 7.1k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (21 papers), Epigenetics and DNA Methylation (7 papers), RNA modifications and cancer (7 papers), High Altitude and Hypoxia (5 papers), Fibroblast Growth Factor Research (4 papers), Mitochondrial Function and Pathology (4 papers), Endoplasmic Reticulum Stress and Disease (4 papers) and Ubiquitin and proteasome pathways (4 papers). The work is most often cited by research in Cancer Research (4.8k citations), Molecular Biology (4.8k citations), Biochemistry (369 citations), Cell Biology (602 citations) and Genetics (987 citations). Matthew E. Cockman has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Peter J. Ratcliffe, Christopher W. Pugh, Patrick H. Maxwell, Gin-Wen Chang, Eamonn R. Maher, Steven C. Clifford, Charles C. Wykoff, Michael S. Wiesener, Norma Masson and David R. Mole. Their work appears in journals such as Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, Oncogene, Chemistry - A European Journal and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact